MyFibroScan Application icon

MyFibroScan 2.4.0

20.1 MB / 5K+ Downloads / Rating 4.3 - 28 reviews


See previous versions

MyFibroScan, developed and published by Echosens Liver IT team, has released its latest version, 2.4.0, on 2024-11-10. This app falls under the Health & Fitness category on the Google Play Store and has achieved over 5000 installs. It currently holds an overall rating of 4.3, based on 28 reviews.

MyFibroScan APK available on this page is compatible with all Android devices that meet the required specifications (Android 5.1+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.echosens.Echosens.MyFibroScan

Updated: 3 months ago

Developer Name: Echosens Liver IT team

Category: Health & Fitness

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing MyFibroScan on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

4.3
Total 28 reviews

Reviews

1 ★, on 2020-06-01
why is this cloud based ? why can I not get a score on my pt, it just says try back later. no computer browser program just smart phone.

2 ★, on 2019-06-28
freezes on LG phones with stock Oreo software. Works fine on non-LG phones or LG with custom PIE software

Previous Versions

MyFibroScan 2.4.0
2024-11-10 / 20.1 MB / Android 5.1+

MyFibroScan 2.3.01
2022-12-04 / 13 MB / Android 5.1+

About this app

FibroScan® is the non-invasive solution for comprehensive management of liver health.

Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.

myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :

The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.

- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.

- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.

- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.

New features

Introduction of novel FibroScan based scores: Agile™ 3+ and Agile™ 4 for the identification of advanced fibrosis and cirrhosis in patients suspected of NAFLD.

App Permissions

Allows applications to open network sockets.
Required to be able to access the camera device.
Allows applications to access information about networks.
Allows an app to use fingerprint hardware.